Dr. El Khoudary was awarded a 2 year grant from the NIH titled “Effects of Hormone Therapy on Heart Fat and Atherosclerosis Progression in Early Postmenopausal Women from the KEEPS Trial”.
Wendy King and Steve Belle, along with co-authors, have published a paper showing that while the proportion of adults with severe obesity using prescription opioids initially declines in the months after bariatric surgery, it increases within a matter of years, eventually surpassing pre-surgery rates of patients using the potentially addictive pain medications.
Anthony Fabio will present the results of the study at the at the 2017 Society for Violence and Injury Research Annual Meeting.
Kathleen Creppage, a DrPH student, presented her dissertation research at Pitt Day in Harrisburg. Dr Rachel Levine stopped by Kathleen’s poster and tweeted a picture of them!
As part of the Approaches and Decisions in Acute Pediatric TBI Trial (ADAPT), EDC faculty member Anthony Fabio will assess the incidence of disruptive behavioral disorders (DBD) after severe TBI.
Wearable fitness devices don’t seem to make you more fit. In an article reviewing research on wearable fitness, the IDEA trial was covered.
The Journal of the AHA recently published the paper titled ‘Postmenopausal Women With Greater Paracardial Fat Have More Coronary Artery Calcification Than Premenopausal Women: The Study of Women’s Health Across the Nation (SWAN) Cardiovascular Fat Ancillary Study’ that associates fat around the heart and a higher risk of heart disease in postmenopausal women.
Dr. El Khoudary has been selected to attend the 2017 Conference on Public Health and Health Sciences for Fulbright Alumni from the middle east and north Africa, which will take place from Monday February 20th to Wednesday February 22nd in Cairo, Egypt.
Wendy King was the recipient this year for her paper, “Prescribed Opioid and Non-Opioid Analgesic Medication Use Before and After Bariatric Surgery: 7 Year Follow-up.”
The EDC will serve as the Data Coordinating Center (DCC) for the Myocardial Ischemia and Transfusion (MINT) trial which was recently funded by the National Heart, Lung, and Blood Institute (NHLBI).